• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Constitutes
© 2025 Longbridge|Disclaimer

Event Tracking

Dec19
CanSino Biologics Starts I Phase Clinical Trial for DTcP-Hib-MCV4 Combination Vaccine
08:35
CanSino Biologics Starts Phase I Clinical Trials for Tetra-valent Vaccine
08:09
Analysts Maintain Buy Rating for Hua Zhu Group, Target Price at HKD 44.00
05:32
CICC report indicates Meituan's fundamentals have passed the left side, maintaining an "Outperform" rating.
05:12
CanSino's Sci-Tech board listing boosts vaccine industrialization
04:52
JPMorgan Expects CICC H Shares to Outperform A Shares
03:22